In the week of September 28, 2026, 21 holders filed a new Schedule 13D and 58 a new Schedule 13G reporting 5% or more of a company. The largest stake reported that week is Tsang Claudius' 80% of BEST SPAC I Acquisition Corp. (Schedule 13D, September 29, 2026).
The week of 2026-09-28, 21 holders filed a new Schedule 13D and 58 a new Schedule 13G reporting 5% or more of a company, and 0 13D filings stated in Item 4 an intent to influence the company. Open a company for every holder and the purpose each 13D states, quoted.
New Schedule 13D
| Filed | Company | Holder | Percent | Filing |
|---|---|---|---|---|
| 2026-09-29 | BEST SPAC I Acquisition Corp. | Tsang Claudius | 80% | SCHEDULE 13D |
| 2026-10-02 | GOWell Energy Technology | Hegro Well Pte. Ltd. ("Hegro") | 74% | SCHEDULE 13D |
| 2026-09-30 | Mercury General Corporation | Vicky Wai Yee Joseph | 35.3% | SCHEDULE 13D |
| 2026-10-01 | Sono Group N.V. | Alpine Fox Capital LLC | 21.5% | SCHEDULE 13D |
| 2026-09-29 | NorthStrive Acquisition Corp I. | PMGC Holdings Inc. | 21.43% | SCHEDULE 13D |
| 2026-10-02 | Soundthinking, Inc. | Gary M. Lauder | 17% | SCHEDULE 13D |
| 2026-10-02 | Zedge, Inc. | Howard S. Jonas | 15.6% | SCHEDULE 13D |
| 2026-10-01 | Inseego Corp | Nokia Solutions and Networks Oy | 14.2% | SCHEDULE 13D |
| 2026-10-02 | ADARx Pharmaceuticals, Inc. | Orbimed Advisors LLC | 14% | SCHEDULE 13D |
| 2026-10-01 | Creative Medical Technology Holdings, Inc. | Timothy Warbington | 13.7% | SCHEDULE 13D |
| 2026-09-30 | 3 E Network Technology Group Limited | 3e Network Technology Pte. Ltd. | 13.4% | SCHEDULE 13D |
| 2026-10-02 | Aterian, Inc. | Michelle Chiam Sin Ling | 10% | SCHEDULE 13D |
| 2026-10-02 | Aterian, Inc. | Chang Woei Jiann | 10% | SCHEDULE 13D |
| 2026-10-02 | GOWell Energy Technology | Inflection Point Fund I, LP | 9.87% | SCHEDULE 13D |
| 2026-10-01 | Canterbury Park Holding Corporation | Gate City Capital Management, LLC | 9.35% | SCHEDULE 13D |
| 2026-09-29 | MoneyHero Ltd | Honig Jonathan | 9% | SCHEDULE 13D |
| 2026-09-29 | BrightSpire Capital, Inc. | CWRE SSF Securities Holding, LP | 8.7% | SCHEDULE 13D |
| 2026-09-29 | People Incorporated | HighSage Ventures LLC | 7.9% | SCHEDULE 13D |
| 2026-09-30 | Silvercrest Asset Management Group Inc. | Equinox Partners Investment Management LLC | 7.1% | SCHEDULE 13D |
| 2026-10-02 | LogicMark, Inc. | Patel Kirtan Sanjaykumar | 5.6% | SCHEDULE 13D |
| 2026-09-30 | Virtus Total Return Fund Inc. | Saba Capital Management, L.P. | 5.04% | SCHEDULE 13D |
New Schedule 13G
| Filed | Company | Holder | Percent | Filing |
|---|---|---|---|---|
| 2026-10-01 | Ticketplus Ltd. | Yethro Dinamarca Santelices | 60.7% | SCHEDULE 13G |
| 2026-10-01 | ETF Opportunities Trust | Katherine Handwerker Whitman | 36.6% | SCHEDULE 13G |
| 2026-10-02 | Innovator ETFs Trust | Brookstone Capital Management, LLC | 22.61% | SCHEDULE 13G |
| 2026-09-29 | AVAX One Technology Ltd. | Philip H. Press | 19.33% | SCHEDULE 13G |
| 2026-10-01 | Ticketplus Ltd. | Chien-Fu Chen Chen | 17.6% | SCHEDULE 13G |
| 2026-09-30 | Arcadia Biosciences, Inc. | MJL Manager LLC | 15.7% | SCHEDULE 13G |
| 2026-10-02 | Alliancebernstein National Municipal Income Fund | Karpus Management, Inc. | 13.57% | SCHEDULE 13G |
| 2026-10-02 | Innovator ETFs Trust | Brookstone Capital Management, LLC | 12.01% | SCHEDULE 13G |
| 2026-10-01 | CoinShares PLC | Newton Russell Paul | 11.6% | SCHEDULE 13G |
| 2026-10-02 | JPMorgan Limited Duration Bond ETF | Weil Company, Inc. | 10.81% | SCHEDULE 13G |
| 2026-09-28 | SBIG Holdings, Inc. | Schuh Todd Arthur | 10.7% | SCHEDULE 13G |
| 2026-10-02 | Blackrock Muniassets Fund, Inc. | Sit Investment Associates Inc | 10.6% | SCHEDULE 13G |
| 2026-10-02 | Build-A-Bear Workshop, Inc. | Pacifica Capital Investments | 10.23% | SCHEDULE 13G |
| 2026-09-30 | IM Cannabis Corp. | Invest Pro Shukai Hon Ltd. | 9.99% | SCHEDULE 13G |
| 2026-09-30 | IM Cannabis Corp. | J.B.D Innovation Ltd. | 9.99% | SCHEDULE 13G |
| 2026-09-30 | IM Cannabis Corp. | L.I.A. Pure Capital Ltd. | 9.99% | SCHEDULE 13G |
| 2026-10-01 | Baird Medical Investment Holdings Ltd | L1 Capital Global Opportunities Master Fund, Ltd. | 9.99% | SCHEDULE 13G |
| 2026-09-30 | Corbus Pharmaceuticals Holdings, Inc. | RA Capital Management, L.P. | 9.9% | SCHEDULE 13G |
| 2026-09-30 | Nuran Wireless Inc. | Posen Joseph Michael | 9.8% | SCHEDULE 13G |
| 2026-10-02 | GOWell Energy Technology | Michael Blitzer | 9.35% | SCHEDULE 13G |
| 2026-10-01 | Under Armour, Inc. | Frasers Group plc | 8.8% | SCHEDULE 13G |
| 2026-09-28 | Electra Therapeutics, Inc. | Redmile Group, LLC | 8.7% | SCHEDULE 13G |
| 2026-10-01 | Brightline Interactive, Inc. | Kronstadt Allen | 7.9% | SCHEDULE 13G |
| 2026-10-01 | Camping World Holdings, Inc. | Wolf Hill Capital Management, LP | 7.7% | SCHEDULE 13G |
| 2026-10-01 | Surrozen, Inc. | Commodore Capital LP | 7.5% | SCHEDULE 13G |
| 2026-10-02 | Axogen, Inc. | Divisadero Street Capital Management, LP | 6.8% | SCHEDULE 13G |
| 2026-10-02 | BNY Mellon Municipal Bond Infrastructure Fund, Inc. | Sit Investment Associates Inc | 6.6% | SCHEDULE 13G |
| 2026-09-29 | Uwm Holdings Corp | OCO Capital GP LLC | 6.43% | SCHEDULE 13G |
| 2026-10-01 | ADARx Pharmaceuticals, Inc. | BCLS Fund III Investments, LP | 6.3% | SCHEDULE 13G |
| 2026-09-28 | NewHold Investment Corp IV | Linden Advisors LP | 6.2% | SCHEDULE 13G |
| 2026-09-29 | Health In Tech, Inc. | Lytton Laurence W | 6.2% | SCHEDULE 13G |
| 2026-09-30 | I3 Verticals Inc | Forager Capital Management, LLC | 6.1% | SCHEDULE 13G |
| 2026-09-28 | Electra Therapeutics, Inc. | LSP 7 Cooperatief U.A. | 6% | SCHEDULE 13G |
| 2026-10-01 | Legacy Education Inc. | Mink Brook Asset Management LLC | 6% | SCHEDULE 13G |
| 2026-10-02 | BNY Mellon Strategic Municipal Bond Fund, Inc. | Sit Investment Associates Inc | 6% | SCHEDULE 13G |
| 2026-10-02 | Autonation, Inc | Brave Warrior Advisors, LLC | 5.83% | SCHEDULE 13G |
| 2026-10-01 | Bluerock Acquisition Corp Ii | Linden Advisors LP | 5.8% | SCHEDULE 13G |
| 2026-09-29 | Sweetgreen, Inc. | Millennium Management LLC | 5.6% | SCHEDULE 13G |
| 2026-09-30 | Stoke Therapeutics Inc | Bvf Partners L P | 5.6% | SCHEDULE 13G |
| 2026-10-02 | Matthews International Corp | Private Capital Management, LLC | 5.59% | SCHEDULE 13G |
| 2026-09-28 | Lantronix, Inc. | Strider Capital, LLC | 5.5% | SCHEDULE 13G |
| 2026-10-02 | Blackstone Long-Short Credit Income Fund | Sit Investment Associates Inc | 5.5% | SCHEDULE 13G |
| 2026-10-01 | Live Oak Acquisition Corp Vi | Sculptor Capital LP | 5.43% | SCHEDULE 13G |
| 2026-09-30 | Indivior Pharmaceuticals, Inc. | Millennium Management LLC | 5.4% | SCHEDULE 13G |
| 2026-09-28 | Mobilicom Ltd | Strider Capital, LLC | 5.3% | SCHEDULE 13G |
| 2026-09-30 | Bcb Bancorp Inc | FJ Capital Management LLC | 5.26% | SCHEDULE 13G |
| 2026-09-28 | Beyond Meat, Inc. | Millennium Management LLC | 5.2% | SCHEDULE 13G |
| 2026-09-29 | Maravai LifeSciences Holdings, Inc. | Millennium Management LLC | 5.2% | SCHEDULE 13G |
| 2026-09-30 | Amerisafe, Inc. | Millennium Management LLC | 5.1% | SCHEDULE 13G |
| 2026-10-01 | Lightspeed Commerce Inc | Pale Fire Capital SICAV a.s. | 5.1% | SCHEDULE 13G |
| 2026-10-01 | Spyre Therapeutics, Inc. | Paradigm BioCapital Advisors LP | 5.1% | SCHEDULE 13G |
| 2026-10-01 | Aura Biosciences Inc | ForGrowth III PA B.V. | 5.1% | SCHEDULE 13G |
| 2026-10-02 | Bny Mellon Strategic Municipals, Inc. | Sit Investment Associates Inc | 5.1% | SCHEDULE 13G |
| 2026-10-02 | UBS Asset Management Income Fund, Inc. | Sit Investment Associates Inc | 5.1% | SCHEDULE 13G |
| 2026-10-02 | Safety Insurance Group Inc | Glazer Capital, LLC | 5.1% | SCHEDULE 13G |
| 2026-09-30 | Silicom Ltd. | Portolan Capital Management, LLC | 5.06% | SCHEDULE 13G |
| 2026-09-30 | Accelerant Holdings | Glazer Capital, LLC | 5% | SCHEDULE 13G |
| 2026-10-01 | John Hancock Comvest Private Income Fund | Manulife (International) Limited | 5% | SCHEDULE 13G |
Stated intent
No 13D this week stated an intent to influence the company.
Tools for this story
Each opens in a new tab. With no account yet, you sign up free and land on the result.
Where this comes from
Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.
Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.